0 works0 citations0 h-index

Glenn Tillotson

Micron (United States)(US)Microbiology Society(GB)

Publications by Year

Research Areas

Clostridium difficile and Clostridium perfringens research, Antibiotic Use and Resistance, Antibiotic Resistance in Bacteria, Pneumonia and Respiratory Infections, Antibiotics Pharmacokinetics and Efficacy

Most-Cited Works

→ Discovery research: the scientific challenge of finding new antibiotics(2011)283 cited
→ Clostridium difficileInfections among Hospitalized Children, United States, 1997–2006(2010)238 cited
→ Acute Exacerbation of COPD(2000)236 cited
→ Acute infective exacerbations of chronic bronchitis(1995)203 cited
→ Bacteroides and related species: The keystone taxa of the human gut microbiota(2024)173 cited
→ Tolerability of Fluoroquinolone Antibiotics Past, Present and Future(1995)168 cited

→ The burden of CDI in the United States: a multifactorial challenge(2023)

154 cited

→ Quinolones: structure-activity relationships and future predictions(1996)140 cited

→ Hematologic Effects of Antimicrobials: Focus on the Oxazolidinone Linezolid(2001)130 cited

→ Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study(2017)116 cited